[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6072 followers
Created: 2025-07-20 10:06:07 UTC

Rossari Biotech Q1 FY26: XX% Revenue Growth & Strategic Expansion Plans 🚀 | MCap XXXXXXXX Cr

- Q1 FY26 revenue: ₹543.7 crore (+11% YoY)
- EBITDA: ₹67.9 crore (+4.6% YoY), margin at XXXX%
- PAT: ₹33.6 crore (-3.7% YoY), margin at XXX%
- HPPC segment grew XX% YoY; TSC declined X% YoY; AHN grew XX% YoY
- Institutional & B2C revenue: ₹70 crore (+9% YoY)
- Core segments (excl. Institutional/B2C): XX% revenue growth, XX% EBITDA margin
- Phased capacity expansion underway, growth expected from FY27
- Strong net debt-to-equity supports future investments
- Diversified base: 1,000+ clients, X facilities (332,100 MTPA capacity)
- Subsidiaries (Unitop, Tristar, Buzil Rossari) show 17%-48% revenue CAGRs
- Focus on green/sustainable chemical solutions
- Management prioritizing efficiency, product mix optimization, and innovation

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of XX pages)

![](https://pbs.twimg.com/media/GwSvqoQaYAA3n6M.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946874253695189358/c:line.svg)

**Related Topics**
[mcap](/topic/mcap)
[quarterly earnings](/topic/quarterly-earnings)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1946874253695189358)